Canada markets closed

Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.08340.0000 (0.00%)
At close: 01:33PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
26
701
52
Operating Expenses
Selling General and Administrative
1,044
1,044
1,058
1,170
1,357
Total Operating Expenses
1,044
1,044
1,058
1,170
1,357
Operating Income or Loss
-1,044
-1,044
-1,032
-469
-1,305
Total Other Income/Expenses Net
-
-
646
7
1
Income Before Tax
1,217
1,217
-386
-462
-1,304
Income Tax Expense
-156
-156
-200
7
7
Income from Continuing Operations
1,373
1,373
-186
-469
-1,311
Net Income
1,373
1,373
-186
-469
-1,311
Net Income available to common shareholders
98
98
-1,461
-2,492
-1,771
Basic EPS
0.00
-
-0.02
-0.03
-0.03
Diluted EPS
0.00
-
-0.02
-0.03
-0.03
Basic Average Shares
74,215
-
74,215
74,215
51,100
Diluted Average Shares
74,215
-
74,215
74,215
51,100